These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 32772941)

  • 1. Retesting for severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Patterns of testing from a large US healthcare system.
    Kennedy AJ; Hilmes MK; Waddell L; Bartow AB; Baxter CM; Hadi CM; Snyder GM; Merlin JS
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):1023-1025. PubMed ID: 32772941
    [No Abstract]   [Full Text] [Related]  

  • 2. Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).
    Lüsebrink J; Schildgen V; Schildgen O
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1529-1532. PubMed ID: 33213555
    [No Abstract]   [Full Text] [Related]  

  • 3. An overview of research on air and environmental contamination with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings.
    Kanamori H
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):130-133. PubMed ID: 33298221
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible contact transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings in Japan, 2020-2021.
    Kurosu H; Watanabe K; Kurosawa K; Nakashita M; Kasamatsu A; Nakamura H; Yamagishi T; Mitsuhashi Y; Yano K; Hachiya Y; Odani T; Amishima M; Nekomiya Y; Matsui T; Yamada M; Kamiyama K; Kikuchi T; Takadate K; Watanabe C; Furusawa Y; Kase K; Hyodo Y; Suzuki H; Matsunaga T; Hori H; Kanoh M; Miyake Y; Yamada M; Kobayashi Y; Sugai M; Suzuki M; Sunagawa T
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1296-1298. PubMed ID: 34039453
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the Healthcare Surface Environment in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Potential Control Measures.
    Kanamori H; Weber DJ; Rutala WA
    Clin Infect Dis; 2021 Jun; 72(11):2052-2061. PubMed ID: 32985671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.
    Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C
    JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Povidone-iodine preprocedural rinse-An evidence-based, second-line defense against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in dental healthcare.
    Maurya RK; Singh H; Kapoor P; Sharma P; Srivastava D
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):822-824. PubMed ID: 33706836
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2), delta variant, between two fully vaccinated healthcare personnel.
    Smith LL; Milstone AM; Jibowu M; Luo CH; Morris CP; Mostafa HH; Maragakis LL
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1983-1985. PubMed ID: 34743764
    [No Abstract]   [Full Text] [Related]  

  • 9. Reconsidering the routine use of contact precautions in preventing the transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings.
    Rodriguez-Nava G; Diekema DJ; Salinas JL
    Infect Control Hosp Epidemiol; 2023 Jun; 44(6):1035-1037. PubMed ID: 37138546
    [No Abstract]   [Full Text] [Related]  

  • 10. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2.
    Shu B; Kirby MK; Davis WG; Warnes C; Liddell J; Liu J; Wu KH; Hassell N; Benitez AJ; Wilson MM; Keller MW; Rambo-Martin BL; Camara Y; Winter J; Kondor RJ; Zhou B; Spies S; Rose LE; Winchell JM; Limbago BM; Wentworth DE; Barnes JR
    Emerg Infect Dis; 2021; 27(7):1821-1830. PubMed ID: 34152951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Disease 2019 Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Positivity in a Large Survey of First Responders and Healthcare Personnel, May-July 2020.
    Akinbami LJ; Petersen LR; Sami S; Vuong N; Lukacs SL; Mackey L; Atas J; LaFleur BJ
    Clin Infect Dis; 2021 Aug; 73(3):e822-e825. PubMed ID: 33515250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare-associated outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a rural hospital in Missouri, March 2020.
    Turabelidze G; Faulconer BC; Lawrence SJ; Pierce A; Smith BK; Fremont DH
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1395-1396. PubMed ID: 33077014
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications-a single-center, prospective, pilot study.
    Mughal MS; Kaur IP; Patton CD; Mikhail NH; Vareechon C; Granet KM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):638-639. PubMed ID: 32530392
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence rate of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among nurses in coronavirus disease 2019 (COVID-19) units versus non-COVID-19-units at a large academic medical center.
    Rivera F; Huerta S; Ahn KW; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2022 Feb; 43(2):257-259. PubMed ID: 34338169
    [No Abstract]   [Full Text] [Related]  

  • 17. Whole-genome Sequencing to Track Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Nosocomial Outbreaks.
    Lucey M; Macori G; Mullane N; Sutton-Fitzpatrick U; Gonzalez G; Coughlan S; Purcell A; Fenelon L; Fanning S; Schaffer K
    Clin Infect Dis; 2021 Jun; 72(11):e727-e735. PubMed ID: 32954414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of long-range severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a highly infectious patient with undiagnosed coronavirus disease 2019 (COVID-19) in a positive-pressure room.
    Rhee C; Baker MA; Tucker R; Klompas M
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):108-109. PubMed ID: 34287114
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 on Self-Collected Saliva or Anterior Nasal Specimens Compared With Healthcare Personnel-Collected Nasopharyngeal Specimens.
    Marx GE; Biggerstaff BJ; Nawrocki CC; Totten SE; Travanty EA; Burakoff AW; Scott T; De Hey JC; Carlson JJ; Wendel KA; Harcourt JL; Tamin A; Thomas JD; Rowan SE; ;
    Clin Infect Dis; 2021 Jul; 73(Suppl 1):S65-S73. PubMed ID: 33912930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Contaminated Surfaces: What Is to Be Done?
    Conover CS
    Clin Infect Dis; 2021 Jun; 72(11):2062-2064. PubMed ID: 33070181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.